Viewing nowCombinationAmlotelm tablet 80/5mg
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Aliko Pharmaceutical Co., Ltd.

MFDS item code 201605814 · Approved 2016.09.30 · Insurance code 656004320
Treatment of essential hypertension not controlled with amlodipine or telmisartan monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or telmisartan. In such cases, the combination of the two medications helps to efficiently control blood pressure. Efficient blood pressure control can reduce the burden on the heart and blood vessels, which is effective in preventing cardiovascular diseases. Since blood pressure control is very important in the treatment of essential hypertension, it is necessary to take this medication continuously according to the healthcare provider's instructions. This combination therapy is used to improve blood pressure and reduce the risk of complications related to hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, a direct switch to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can pose serious risks to the fetus, especially during the second and third trimesters of pregnancy; therefore, if pregnancy is confirmed, discontinuation should occur immediately. This medication should not be used in patients with hypersensitivity to the active ingredient, pregnant or breastfeeding women, and patients with severe problems with the liver or heart. Patients with impaired liver function or cholestatic diseases, severe hypotension, or heart failure should use this medication with special caution. This medication lowers blood pressure, so patients who are deficient in body fluids or salt may experience symptoms of hypotension, and in such cases, immediate consultation with healthcare professionals is necessary. There is a risk of increased serum potassium levels, so caution is needed when taking potassium-rich foods or medications together, and regular blood tests are recommended. Patients with impaired kidney function should regularly monitor their kidney function and serum electrolyte levels while taking this medication. This medication may cause dizziness or drowsiness, so it is advisable to avoid driving or operating hazardous machinery during treatment. Drug interactions may occur when taken with other antihypertensive medications or certain drugs, so all medications currently being taken should be reported to healthcare providers. Overdose of this medication can lead to severe hypotension or heart problems, so the prescribed dosage must be strictly followed, and in case of overdose, immediate medical attention is required. This medication is not recommended for children and adolescents under the age of 18. Elderly patients may respond more sensitively to this medication, so caution and dosage adjustments should be made when administering it.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that blocks light and allows air to circulate, at a temperature between 1 degree and 30 degrees Celsius. Storing it this way helps to maintain the medication's efficacy and prevents degradation.
It is a round, biconvex, oval-shaped double tablet that is white and light blue.
30 tablets (10 tablets/PTP x 3), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Aliko Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.